142 related articles for article (PubMed ID: 28052934)
1. Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention.
Seabloom DE; Galbraith AR; Haynes AM; Antonides JD; Wuertz BR; Miller WA; Miller KA; Steele VE; Miller MS; Clapper ML; O'Sullivan MG; Ondrey FG
Cancer Prev Res (Phila); 2017 Feb; 10(2):116-123. PubMed ID: 28052934
[TBL] [Abstract][Full Text] [Related]
2. Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice.
Seabloom DE; Galbraith AR; Haynes AM; Antonides JD; Wuertz BR; Miller WA; Miller KA; Steele VE; Suen CS; O'Sullivan MG; Ondrey FG
Cancer Prev Res (Phila); 2017 Feb; 10(2):124-132. PubMed ID: 27993834
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice.
Fu H; Zhang J; Pan J; Zhang Q; Lu Y; Wen W; Lubet RA; Szabo E; Chen R; Wang Y; Chen DR; You M
Mol Carcinog; 2011 Dec; 50(12):913-21. PubMed ID: 21374736
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.
Perez A; Zhao Z; Jacks R; Spanheimer R
Curr Med Res Opin; 2009 Dec; 25(12):2915-23. PubMed ID: 19827910
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes.
DeFronzo RA; Burant CF; Fleck P; Wilson C; Mekki Q; Pratley RE
J Clin Endocrinol Metab; 2012 May; 97(5):1615-22. PubMed ID: 22419732
[TBL] [Abstract][Full Text] [Related]
6. Oral antidiabetic drugs: effect of food on absorption of pioglitazone and metformin from a fixed-dose combination tablet.
Karim A; Slater M; Bradford D; Schwartz L; Laurent A
J Clin Pharmacol; 2007 Jan; 47(1):48-55. PubMed ID: 17192501
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
[TBL] [Abstract][Full Text] [Related]
8. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
Barner JC
Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
[TBL] [Abstract][Full Text] [Related]
9. Metformin in lung cancer: rationale for a combination therapy.
Morgillo F; Sasso FC; Della Corte CM; Festino L; Manzo A; Martinelli E; Troiani T; Capuano A; Ciardiello F
Expert Opin Investig Drugs; 2013 Nov; 22(11):1401-9. PubMed ID: 23937224
[TBL] [Abstract][Full Text] [Related]
10. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action and effect of immune-modulating agents in the treatment of psoriasis.
El-Gharabawy RM; Ahmed AS; Al-Najjar AH
Biomed Pharmacother; 2017 Jan; 85():141-147. PubMed ID: 27930978
[TBL] [Abstract][Full Text] [Related]
12. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
[TBL] [Abstract][Full Text] [Related]
13. Appropriate insulin initiation dosage for insulin-naive type 2 diabetes outpatients receiving insulin monotherapy or in combination with metformin and/or pioglitazone.
Liao L; Yang M; Qiu LL; Mou YR; Zhao JJ; Dong JJ
Chin Med J (Engl); 2010 Dec; 123(24):3684-8. PubMed ID: 22166651
[TBL] [Abstract][Full Text] [Related]
14. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.
Ortega-González C; Luna S; Hernández L; Crespo G; Aguayo P; Arteaga-Troncoso G; Parra A
J Clin Endocrinol Metab; 2005 Mar; 90(3):1360-5. PubMed ID: 15598674
[TBL] [Abstract][Full Text] [Related]
15. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
Umpierrez G; Issa M; Vlajnic A
Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
[TBL] [Abstract][Full Text] [Related]
16. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP
Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive effects of pioglitazone on chemically induced lung carcinogenesis in mice.
Wang Y; James M; Wen W; Lu Y; Szabo E; Lubet RA; You M
Mol Cancer Ther; 2010 Nov; 9(11):3074-82. PubMed ID: 21045137
[TBL] [Abstract][Full Text] [Related]
18. Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice.
Estensen RD; Wattenberg LW
Carcinogenesis; 1993 Sep; 14(9):1975-7. PubMed ID: 8403228
[TBL] [Abstract][Full Text] [Related]
19. A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.
St Charles M; Minshall ME; Pandya BJ; Baran RW; Tunis SL
Curr Med Res Opin; 2009 Jun; 25(6):1343-53. PubMed ID: 19419339
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone plus a sulphonylurea or metformin is associated with increased lipoprotein particle size in patients with type 2 diabetes.
Perez A; Khan M; Johnson T; Karunaratne M
Diab Vasc Dis Res; 2004 May; 1(1):44-50. PubMed ID: 16305056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
